216 related articles for article (PubMed ID: 24637461)
21. Interleukin-18 enhances breast cancer cell migration via down-regulation of claudin-12 and induction of the p38 MAPK pathway.
Yang Y; Cheon S; Jung MK; Song SB; Kim D; Kim HJ; Park H; Bang SI; Cho D
Biochem Biophys Res Commun; 2015 Apr; 459(3):379-86. PubMed ID: 25727011
[TBL] [Abstract][Full Text] [Related]
22. Autocrine CSF1R signaling mediates switching between invasion and proliferation downstream of TGFβ in claudin-low breast tumor cells.
Patsialou A; Wang Y; Pignatelli J; Chen X; Entenberg D; Oktay M; Condeelis JS
Oncogene; 2015 May; 34(21):2721-31. PubMed ID: 25088194
[TBL] [Abstract][Full Text] [Related]
23. Guanylate binding protein-1-mediated epithelial barrier in human salivary gland duct epithelium.
Konno T; Takano K; Kaneko Y; Kakuki T; Nomura K; Yajima R; Kakiuchi A; Kohno T; Himi T; Kojima T
Exp Cell Res; 2018 Oct; 371(1):31-41. PubMed ID: 30044945
[TBL] [Abstract][Full Text] [Related]
24. Expression and function of tight junction associated molecules in human breast tumor cells is not affected by the Ras-MEK1 pathway.
Macek R; Swisshelm K; Kubbies M
Cell Mol Biol (Noisy-le-grand); 2003 Feb; 49(1):1-11. PubMed ID: 12839332
[TBL] [Abstract][Full Text] [Related]
25. BRCA Mutation-Related and Claudin-Low Breast Cancer: Blood Relatives or Stepsisters.
Madaras L; Balint N; Gyorffy B; Tokes AM; Barshack I; Yosepovich A; Friedman E; Paluch-Shimon S; Zippel D; Baghy K; Timar J; Kovalszky I; Kulka J; Szasz AM
Pathobiology; 2016; 83(1):1-12. PubMed ID: 26566278
[TBL] [Abstract][Full Text] [Related]
26. Claudin-3 and claudin-19 partially restore native phenotype to ARPE-19 cells via effects on tight junctions and gene expression.
Peng S; Wang SB; Singh D; Zhao PY; Davis K; Chen B; Adelman RA; Rizzolo LJ
Exp Eye Res; 2016 Oct; 151():179-89. PubMed ID: 27593915
[TBL] [Abstract][Full Text] [Related]
27. Loss of LSR affects epithelial barrier integrity and tumor xenograft growth of CaCo-2 cells.
Czulkies BA; Mastroianni J; Lutz L; Lang S; Schwan C; Schmidt G; Lassmann S; Zeiser R; Aktories K; Papatheodorou P
Oncotarget; 2017 Jun; 8(23):37009-37022. PubMed ID: 27391068
[TBL] [Abstract][Full Text] [Related]
28. Claudin 4 expression in triple-negative breast cancer: correlation with androgen receptors and Ki-67 expression.
Abd-Elazeem MA; Abd-Elazeem MA
Ann Diagn Pathol; 2015 Feb; 19(1):37-42. PubMed ID: 25456318
[TBL] [Abstract][Full Text] [Related]
29. Neuropilin-1 is over-expressed in claudin-low breast cancer and promotes tumor progression through acquisition of stem cell characteristics and RAS/MAPK pathway activation.
Tang YH; Rockstroh A; Sokolowski KA; Lynam LR; Lehman M; Thompson EW; Gregory PA; Nelson CC; Volpert M; Hollier BG
Breast Cancer Res; 2022 Jan; 24(1):8. PubMed ID: 35078508
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of lipolysis-stimulated lipoprotein receptor promotes cell invasion via claudin-1-mediated matrix metalloproteinases in human endometrial cancer.
Shimada H; Satohisa S; Kohno T; Konno T; Takano KI; Takahashi S; Hatakeyama T; Arimoto C; Saito T; Kojima T
Oncol Lett; 2017 Dec; 14(6):6776-6782. PubMed ID: 29151917
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of claudin expression changes in breast cancer with regional lymph node metastasis.
Szasz AM; Tokes AM; Micsinai M; Krenacs T; Jakab C; Lukacs L; Nemeth Z; Baranyai Z; Dede K; Madaras L; Kulka J
Clin Exp Metastasis; 2011 Jan; 28(1):55-63. PubMed ID: 20963473
[TBL] [Abstract][Full Text] [Related]
32. Pyk2-dependent phosphorylation of LSR enhances localization of LSR and tricellulin at tricellular tight junctions.
Nakatsu D; Kano F; Shinozaki-Narikawa N; Murata M
PLoS One; 2019; 14(10):e0223300. PubMed ID: 31574128
[TBL] [Abstract][Full Text] [Related]
33. [Effects of stable up-regulation of tight junction protein claudin-6 upon biological phenotypes of breast cancer cell MCF-7].
Wu Q; Liu YF; Ren Y; Xu XM; Yu LN; Li YL; Quan CS
Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(6):407-12. PubMed ID: 20367941
[TBL] [Abstract][Full Text] [Related]
34. LSR Promotes Cell Proliferation and Invasion in Lung Cancer.
Zhang M; Ma C
Comput Math Methods Med; 2021; 2021():6651907. PubMed ID: 33763152
[TBL] [Abstract][Full Text] [Related]
35. Role of Tricellular Tight Junction Protein Lipolysis-Stimulated Lipoprotein Receptor (LSR) in Cancer Cells.
Kohno T; Konno T; Kojima T
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31330820
[TBL] [Abstract][Full Text] [Related]
36. Emerging roles of claudins in human cancer.
Kwon MJ
Int J Mol Sci; 2013 Sep; 14(9):18148-80. PubMed ID: 24009024
[TBL] [Abstract][Full Text] [Related]
37. Claudin expression in breast cancer: high or low, what to expect?
Ricardo S; Gerhard R; Cameselle-Teijeiro JF; Schmitt F; Paredes J
Histol Histopathol; 2012 Oct; 27(10):1283-95. PubMed ID: 22936447
[TBL] [Abstract][Full Text] [Related]
38. Age-related changes in regiospecific expression of Lipolysis Stimulated Receptor (LSR) in mice brain.
El Hajj A; Yen FT; Oster T; Malaplate C; Pauron L; Corbier C; Lanhers MC; Claudepierre T
PLoS One; 2019; 14(6):e0218812. PubMed ID: 31233547
[TBL] [Abstract][Full Text] [Related]
39. Histone deacetylase inhibition prevents cell death induced by loss of tricellular tight junction proteins in temperature-sensitive mouse cochlear cells.
Takano K; Kakuki T; Kaneko Y; Kohno T; Kikuchi S; Himi T; Kojima T
PLoS One; 2017; 12(8):e0182291. PubMed ID: 28767685
[TBL] [Abstract][Full Text] [Related]
40. Claudin 1 expression in basal-like breast cancer is related to patient age.
Blanchard AA; Ma X; Dueck KJ; Penner C; Cooper SC; Mulhall D; Murphy LC; Leygue E; Myal Y
BMC Cancer; 2013 May; 13():268. PubMed ID: 23721519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
